Refresh
Gainers Losers Sectors Indices Forex Mutual Funds

Mahaalaxmi Texpro Ltd.

Price on BSE   13 Dec,00:00 LIVE
0.57
+0.02
(+3.64%)

© 2026 Rediff.com
  • Volume :
  • 300.00
  • Prev Close :
  • 0.55
  • Day's H/L (Rs.) :
  • 0.57 - 0.57
  • 52wk H/L (Rs.) :
  • 0.57 - 0.49
  • Mkt Cap (Rs. Cr) :
  • 0.91
Mahaalaxmi Texpro Ltd. is not listed on NSE

© 2026 Rediff.com
Report Card - Mahaalaxmi Texpro Ltd.
PE Ratios
EPS (Rs.)
-15.79
Sales (Rs. Cr)
Face Value (Rs.)
10
Net Profit Margin(%)
-547.05
Last Bonus
-
Last Dividend(%)
-
Return on Average Equity

News for Miscellaneous

India Real Estate: Capital Inflows Rise 72% to $5.1 Billion
Indian real estate sees record $5.1 billion capital inflow in Jan-Mar, a 72% rise. Developers & REITs drive growth despite global uncertainty.
Apr 22, 2026 11:03
Ajanta Pharma Gets USFDA Form 483 with 5 Observations
USFDA issues Form 483 with five observations to Ajanta Pharma's Paithan facility in Maharashtra after inspection. Company to respond soon.
Apr 22, 2026 10:59
Lupin Launches Anti-Diabetic Tablets in US
Lupin launches generic dapagliflozin and metformin hydrochloride extended-release tablets in the US after USFDA approval.
Apr 22, 2026 10:51
HCLTech Shares Tank After Earnings
HCLTech shares fell nearly 10% after March quarter earnings. FY27 growth guidance is 1-4%. AI revenue crosses $620M.
Apr 22, 2026 10:48
RBI Monitors FDI Outflows, Exchange Rates
RBI Governor Sanjay Malhotra closely monitors short-term fluctuations like FDI outflows and exchange rate movements. India's strong macroeconomic fundamentals highlighted.
Apr 22, 2026 10:48

More News »

Top News

India Real Estate: Capital Inflows Rise 72% to $5.1 Billion
Indian real estate sees record $5.1 billion capital inflow in Jan-Mar, a 72% rise. Developers & REITs drive growth despite global uncertainty.
Apr 22, 2026 11:03
Ajanta Pharma Gets USFDA Form 483 with 5 Observations
USFDA issues Form 483 with five observations to Ajanta Pharma's Paithan facility in Maharashtra after inspection. Company to respond soon.
Apr 22, 2026 10:59
Lupin Launches Anti-Diabetic Tablets in US
Lupin launches generic dapagliflozin and metformin hydrochloride extended-release tablets in the US after USFDA approval.
Apr 22, 2026 10:51
HCLTech Shares Tank After Earnings
HCLTech shares fell nearly 10% after March quarter earnings. FY27 growth guidance is 1-4%. AI revenue crosses $620M.
Apr 22, 2026 10:48
RBI Monitors FDI Outflows, Exchange Rates
RBI Governor Sanjay Malhotra closely monitors short-term fluctuations like FDI outflows and exchange rate movements. India's strong macroeconomic fundamentals highlighted.
Apr 22, 2026 10:48

More Top News »

Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2026 Rediff.com